SARCopeniA and exeRcisE in older adults: a randomized controlled trial

Geneva University Hospitals0 sites196 target enrollmentJune 1, 2017

Overview

No summary available.

Registry

who.int

Start Date

June 1, 2017

End Date

March 31, 2020

Last Updated

3 years ago

Study Type

Interventional

Sex

All

Sponsor

Geneva University Hospitals

•1\. Age \=65 years (no upper age limit)
•2\. Short Physical Performance Battery (SPPB) score between 3 and 9, inclusive
•3\. Presence of low muscle mass according to the Baumgartner definition
•4\. Able to complete the 400 m walk test within 15 minutes without sitting or the help of another person, or the use of a walker
•5\. Willingness to give informed consent, to be randomized to one of the two study groups, and comply with all study requirements

•People are excluded from participation in the study for any condition likely to affect the safety of the intervention and/or limit lifespan, or factors that may limit adherence to intervention or affect conduct of the trial (e.g., physical limitations should not be clearly attributable to the direct effect of a specific disease). In particular, exclusion criteria applied are:
•1\. Resides in a nursing home or is hospitalized
•2\. Diagnosis of dementia or score \<21 on the MMSE
•3\. Serious neurological, neuromuscular or orthopaedic condition (e.g.,Parkinson's disease)
•4\. Serious cardiovascular or pulmonary condition (including myocardial infarction in previous 6 months) or development of chest pain or severe shortness of breath on the 400 m walk test
•5\. Participation in a supervised music\-based multitask exercise program in the past 12 months